These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
614 related articles for article (PubMed ID: 26013324)
21. Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer. Kunisaki C; Takahashi M; Makino H; Oshima T; Fujii S; Takagawa R; Kimura J; Kosaka T; Ono HA; Akiyama H; Kameda K; Kito F; Morita S; Endo I Cancer Chemother Pharmacol; 2011 Jun; 67(6):1363-8. PubMed ID: 20803016 [TBL] [Abstract][Full Text] [Related]
22. Phase I study of combination chemotherapy consisting of paclitaxel, cisplatin, and S-1 in patients with unresectable gastric cancer (KOGC-02). Takahashi T; Saikawa Y; Fukuda K; Funakoshi S; Kawakubo H; Takeuchi H; Takaishi H; Kitagawa Y Anticancer Res; 2012 Dec; 32(12):5401-6. PubMed ID: 23225443 [TBL] [Abstract][Full Text] [Related]
23. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial. Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T; Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061 [TBL] [Abstract][Full Text] [Related]
24. Effect of the weekly administration of liposome-Paclitaxel combined with s-1 on advanced gastric cancer. Chen L; Chen Q; Zhuang Z; Zhang Y; Tao J; Shen L; Shen X; Chen Z; Wang J; Zhu M; Wang H Jpn J Clin Oncol; 2014 Mar; 44(3):208-13. PubMed ID: 24453274 [TBL] [Abstract][Full Text] [Related]
25. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer. Wang F; Wang Z; Zhou N; An X; Xu R; He Y; Li Y Am J Clin Oncol; 2011 Aug; 34(4):401-5. PubMed ID: 21791984 [TBL] [Abstract][Full Text] [Related]
26. A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer. Rino Y; Takanashi Y; Yukawa N; Saeki H; Wada H; Kanari M; Yamada R; Satoh T; Yamamoto N; Imada T Anticancer Res; 2006; 26(2B):1455-62. PubMed ID: 16619558 [TBL] [Abstract][Full Text] [Related]
27. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805 [TBL] [Abstract][Full Text] [Related]
28. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer. Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531 [TBL] [Abstract][Full Text] [Related]
29. Feasibility study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 for advanced gastric cancer. Fujitani K; Hasegawa H; Hirao M; Kurokawa Y; Tsujinaka T Anticancer Res; 2011 Sep; 31(9):3085-91. PubMed ID: 21868564 [TBL] [Abstract][Full Text] [Related]
30. Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases. Shi M; Yang Z; Lu S; Liu W; Ni Z; Yao X; Hua Z; Feng R; Zheng Y; Wang Z; Sah BK; Chen M; Zhu Z; He C; Li C; Zhang J; Yan C; Yan M; Zhu Z BMC Cancer; 2021 Dec; 21(1):1344. PubMed ID: 34922478 [TBL] [Abstract][Full Text] [Related]
31. Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer. Lee JL; Kang HJ; Kang YK; Ryu MH; Chang HM; Kim TW; Sohn HJ; Kim H; Lee JS Cancer Chemother Pharmacol; 2008 Apr; 61(5):837-45. PubMed ID: 17579864 [TBL] [Abstract][Full Text] [Related]
32. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer. Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549 [TBL] [Abstract][Full Text] [Related]
33. Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer. Lee KW; Im SA; Yun T; Song EK; Na Ii; Shin H; Choi IS; Oh DY; Kim JH; Kim DW; Kim TY; Lee JS; Heo DS; Bang YJ; Kim NK Jpn J Clin Oncol; 2005 Dec; 35(12):720-6. PubMed ID: 16332718 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and feasibility of combination chemotherapy with S-1 and cisplatin (2 weeks regimen) for advanced gastric cancer. Abe S; Tsuji Y; Tsushima T; Kogawa T; Abe M; Onodera Y; Mizushima T; Kukitsu T; Sumiyoshi T; Yoshizaki N; Ishii T; Kondo H Jpn J Clin Oncol; 2010 Apr; 40(4):302-6. PubMed ID: 20089529 [TBL] [Abstract][Full Text] [Related]
35. A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis. Imano M; Peng YF; Itoh T; Nishikawa M; Satou T; Yasuda A; Inoue K; Kato H; Shinkai M; Tsubaki M; Yasuda T; Imamoto H; Nishida S; Furukawa H; Takeyama Y; Okuno K; Shiozaki H Anticancer Res; 2012 Sep; 32(9):4071-5. PubMed ID: 22993363 [TBL] [Abstract][Full Text] [Related]
36. A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601). Koizumi W; Nakayama N; Tanabe S; Sasaki T; Higuchi K; Nishimura K; Takagi S; Azuma M; Ae T; Ishido K; Nakatani K; Naruke A; Katada C Cancer Chemother Pharmacol; 2012 Feb; 69(2):407-13. PubMed ID: 21796483 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. Sato Y; Takayama T; Sagawa T; Takahashi Y; Ohnuma H; Okubo S; Shintani N; Tanaka S; Kida M; Sato Y; Ohta H; Miyanishi K; Sato T; Takimoto R; Kobune M; Yamaguchi K; Hirata K; Niitsu Y; Kato J Cancer Chemother Pharmacol; 2010 Sep; 66(4):721-8. PubMed ID: 20041328 [TBL] [Abstract][Full Text] [Related]
38. Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer. Kawabata R; Fujiwara Y; Doki Y; Fujita J; Tsukahara Y; Yamasaki M; Miyata H; Takiguchi S; Monden M Oncology; 2007; 72(3-4):219-25. PubMed ID: 18176087 [TBL] [Abstract][Full Text] [Related]
39. Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701). Nakanishi K; Kobayashi D; Mochizuki Y; Ishigure K; Ito S; Kojima H; Ishiyama A; Fujitake S; Shikano T; Morita S; Kodera Y Int J Clin Oncol; 2016 Jun; 21(3):557-65. PubMed ID: 26547424 [TBL] [Abstract][Full Text] [Related]
40. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02. Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]